Filter
467
Filtered Results: 467
Text search:
Georgy,
V.
Featured
Recommendations
28
New Publications
94
Language
Document type
No document type
261
Studies & Reports
99
Guidelines
55
Manuals
24
Strategic & Response Plan
13
Training Material
7
Fact sheets
6
Situation Updates
2
Countries / Regions
Global
22
Germany
22
India
21
Western and Central Europe
14
Kenya
13
South Africa
13
Ghana
11
Malawi
11
Uganda
9
Ukraine
8
Tanzania
8
Russia
8
Zambia
8
Brazil
7
Latin America and the Carribbean
6
Liberia
6
Rwanda
5
Africa
5
Eastern Europe
5
Sierra Leone
4
Zimbabwe
4
Nigeria
3
Mozambique
3
USA
3
Asia
3
Congo, Democratic Republic of
3
Lesotho
2
Senegal
2
Philippines
2
Haiti
2
Venezuela
2
Angola
2
Eswatini/ Swaziland
2
Tajikistan
1
Nepal
1
Benin
1
Gambia
1
China
1
Cameroon
1
Syria
1
Burkina Faso
1
Peru
1
Mongolia
1
Guinea
1
Guinea-Bissau
1
Lithuania
1
West and Central Africa
1
Eastern Europe and Central Asia
1
Southern Africa
1
Côte d’Ivoire / Ivory Coast
1
Bolivia
1
Argentina
1
Lebanon
1
Bangladesh
1
Moldova
1
Georgia
1
Ethiopia
1
Botswana
1
Authors & Publishers
Publication Years
Category
Countries
141
Clinical Guidelines
47
Public Health
33
Key Resources
20
Women & Child Health
14
Capacity Building
5
Pharmacy & Technologies
2
Toolboxes
Mental Health
60
HIV
50
COVID-19
30
Planetary Health
24
TB
21
NTDs
19
Caregiver
17
Disability
15
NCDs
14
Refugee
13
Global Health Education
11
Social Ethics
9
Natural Hazards
8
AMR
8
Rapid Response
7
Ebola & Marburg
7
Pharmacy
6
Zika
4
Conflict
3
Specific Hazards
2
Health Financing Toolbox
2
Cholera
1
Malaria
1
Key questions
What is already known?
Critical illness is common throughout the world and COVID-19 has caused a global surge of critically ill patients.
There are large gaps in the quality of care for critically ill patients, especially in low-staffed and low-resourced settings, and mortal...
PLOS ONE | https://doi.org/10.1371/journal.pone.0210937
February 5, 2019
The WHO Living guideline: Drugs to prevent COVID-19 contains the Organization’s most up-to-date recommendations for the use of drugs to prevent COVID-19. The latest version of this living guideline is available in pdf format (via the ‘Download’ button) and via an online platform.
Guidelines ...
Special issue: Mental Health Challenges in Lithuania
Nos. 1-2 '11
The Guidelines on promotive and preventive mental health interventions for adolescents - Helping Adolescents thrive (HAT), provide evidence-informed recommendations on psychosocial interventions to promote mental health, prevent mental disorders, and reduce self-harm and other risk behaviours among ...
Oral health is defined as the absence of disease and a status that ensures optimal functioning of the mouth and its tissues in a manner preserving the highest level of function and self-esteem. Oral health enables an individual to eat, speak and socialise having no active disease, discomfort or disc...
Barriers to HIV Services and Treatment for Persons with Disabilities in Zambia
The 80-page report documents the obstacles faced by people with disabilities in both the community and healthcare settings. These include pervasive stigma and discrimination, lack of access to inclusive HIV prevention ed...
2nd edition.
The tool kit provides learning objects and curricular content to support the competencies for those proficiency/trainee levels
Journal of Social Aspects of HIV/AIDS VOL. 14 NO. 1 2017
SAHARA J. 2017; 14(1): 77–84.
Published online 2017 Sep 21. doi: 10.1080/17290376.2017.1374878
PMCID: PMC5639614
PMID: 28934916
HTS Teologiese Studies/Theological StudiesISSN: (Online) 2072-8050, (Print) 0259-9422P
Member States have requested WHO policy guidance on how to facilitate the implementation of national AMS activities in an integrated and programmatic approach. This policy guidance responds to that demand from Member States and is anchored in public health guiding principles in the human health sect...
Esta primeira versão de Medicamentos para prevenção da COVID-19: Orientação dinâmica da OMS aborda o uso de hidroxicloroquina para prevenção da COVID-19. Segue-se a publicação de uma análise sistemática e NMA que reuniu dados de seis estudos com 6.059 participantes que não tinham COVID-...
Time has seen management for Cystic Fibrosis (CF) advance drastically, most recently in the development of the disease-modifying triple combination therapy ivacaftor/tezacaftor/elexacaftor. There is currently limited evidence regarding both the global epidemiology of CF and access to this transforma...
Disaster Recovery Toolkit
